| Schedule of Segment Reporting |
Selected financial information for the Company’s
operating segments is as follows:
| |
|
Year Ended December 31, |
|
| |
|
2017 |
|
|
2016 |
|
| Net revenues - External |
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
2,793,089 |
|
|
$ |
3,338,425 |
|
| Hospital Operations |
|
|
1,826,384 |
|
|
|
- |
|
| |
|
$ |
4,619,473 |
|
|
$ |
3,338,425 |
|
| (Loss) income from operations |
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
(4,672,768 |
) |
|
$ |
(12,946,144 |
) |
| Hospital Operations |
|
|
(4,800,539 |
) |
|
|
- |
|
| Corporate |
|
|
(6,602,800 |
) |
|
|
(9,545,763 |
) |
| |
|
$ |
(16,076,107 |
) |
|
$ |
(22,491,907 |
) |
| Depreciation and amortization |
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
1,639,954 |
|
|
$ |
2,412,040 |
|
| Hospital Operations |
|
|
73,985 |
|
|
|
- |
|
| Corporate |
|
|
1,382 |
|
|
|
3,008 |
|
| |
|
$ |
1,715,321 |
|
|
$ |
2,415,048 |
|
| Capital expenditures |
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
- |
|
|
$ |
14,123 |
|
| Hospital Operations |
|
|
1,422,002 |
|
|
|
- |
|
| |
|
$ |
1,422,002 |
|
|
$ |
14,123 |
|
| |
|
Year Ended December 31, |
|
| |
|
2017 |
|
|
2016 |
|
| Total assets |
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
1,503,520 |
|
|
$ |
4,637,984 |
|
| Hospital Operations |
|
|
2,549,504 |
|
|
|
- |
|
| Corporate |
|
|
3,436,773 |
|
|
|
2,130,191 |
|
| Assets of AMSG and HTS classified as held for sale |
|
|
255,566 |
|
|
|
821,449 |
|
| Eliminations |
|
|
(1,454,570 |
) |
|
|
(1,107,231 |
) |
| |
|
$ |
6,290,794 |
|
|
$ |
6,482,393 |
|
|